1. Market Research
  2. > Pharmaceutical
  3. > Drug and Medication Market Trends
  4. > Analysis of Emerging Microbiology Tests and Strategic Profiles of Leading Suppliers

This 760-page report presents a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for nearly 100 infectious diseases and viruses, including their scientific background, clinical significance and market needs for new tests, vaccines, drugs and extensive listings of companies developing or marketing innovative technologies and products.

The report also presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. 

Contains 760 pages and 31 tables

Table Of Contents

Analysis of Emerging Microbiology Tests and Strategic Profiles of Leading Suppliers
Table of Contents

1. AIDS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Adenovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
3. Aeromonas
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Anthrax/Bacillus Anthracis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Arboviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Babesiosis
a. Background
7. Bacillary Epithelioid Angiomatosis (BEA)
And Other Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Blastocystis Hominis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. Brucella
a. Background
b. Diagnostic Tests
c. Vaccines and DrugsTable of Contents (continued)
10. Campylobacter
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
11. Candida
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. Chagas Disease
a. Background
13. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. Chlamydia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
15. Clostridium Difficile
a. Background
b. Diagnostic Tests
c. Drugs and Vaccines
16. Coronaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. Coxsackieviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
18. Creutzfeldt-Jakob's Disease
a. Background
b. Diagnostic Tests
c. Vaccines
19. Cryptosporidium Parvum
a. Background
b. Diagnostic Tests
c. Vaccines and DrugsTable of Contents (continued)
20. Cyclospora Cayetanensis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
21. Cytomegalovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
22. Ebola Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
23. E. Coli
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
24. EchoVirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
25. Encephalitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
26. Enteroviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
27. Epstein-Barr Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
28. Giardia Lamblia
a. Background
b. Diagnostic Tests
c. Vaccines and DrugsTable of Contents (continued)
29. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
30. Granuloma Inguinale
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
31. Hantavirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
32. Helicobacter Pylori
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
33. Hepatitis
a. Background
b. Hepatitis A
c. Hepatitis B
d. Hepatitis C
e. Vaccines and Drugs
34. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
35. Human Herpes Virus-6 (HHV-6)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
36. Influenza Viruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
37. Legionella
a. Background
b. Diagnostic Tests
c. Vaccines and DrugsTable of Contents (continued)
38. Lyme Disease
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
39. Lymphogranuloma Venereum (LGV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
40. Malaria
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
41. Measles (Rubeola)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
42. Meningitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
43. Microsporidium
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
44. Mononucleosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
45. Mumps
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
46. Mycoplasma
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
47. Papillomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and DrugsTable of Contents (continued)
48. Parvovirus B19
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
49. Pneumonia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
50. Polyomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
51. Pseudomonas Aeruginosa
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
52. Rabies
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
53. Respiratory Syncytial Virus (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
54. RhinoViruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
55. RotaVirus (REOVIRUS)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
56. Rubella(MEASLES)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
57. Salmonellosis
a. Background
b. Diagnostic Tests
c. Vaccines and DrugsTable of Contents (continued)
58. Septicemia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
59. Shigellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
60. Staphylococcus Aureus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
61. Streptococci
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
62. Syphilis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
63. Toxoplasmosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
64. Trichomonas Vaginalis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
65. Tuberculosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
66. Vibrio
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
67. West Nile Virus
a. Background
b. Diagnostic Tests
c. Vaccines and DrugsTable of Contents (continued)
68. Yersina
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Competitive Profiles
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Enzo Biochem
- Fujirebio
- Gen-Probe
- Hologic
- ID Biomedical
- Innogenetics/Solvay
- Kreatech
- Life Technology
- Lonza
- Nanogen/Elitech
- Novartis Diagnostics
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac
- Wako

List of Tables

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma TestsList of Tables (continued)
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

2015 New Frontiers in Point-of-Care/POC Diagnostic Testing: Global Challenges, Emerging Technologies, Competitive Landscape

2015 New Frontiers in Point-of-Care/POC Diagnostic Testing: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 16 600
  • Industry report
  • June 2015
  • by Venture Planning Group

“2015 New Frontiers in Point-of-Care/POC Diagnostic Testing: Global Challenges, Emerging Technologies, Competitive Landscape” is VPGMarketResearch’s new report, which provides comprehensive analysis ...

2015-2019 Point-of-Care/POC Diagnostic Testing Market: Supplier Shares, Country Forecasts for 300 Tests, Emerging Technologies, Competitive Strategies

2015-2019 Point-of-Care/POC Diagnostic Testing Market: Supplier Shares, Country Forecasts for 300 Tests, Emerging Technologies, Competitive Strategies

  • $ 16 600
  • Industry report
  • June 2015
  • by Venture Planning Group

“2015-2019 Point-of-Care/POC Diagnostic Testing Market: Supplier Shares, Country Forecasts for 300 Tests, Emerging Technologies, Competitive Strategies” is VPGMarketResearch’s new report, which provides ...

2015-2019 Decentralized/POC Diagnostic Testing Market: Supplier Shares, Country Forecasts for 300 Tests, Emerging Technologies, Competitive Strategies

2015-2019 Decentralized/POC Diagnostic Testing Market: Supplier Shares, Country Forecasts for 300 Tests, Emerging Technologies, Competitive Strategies

  • $ 16 600
  • Industry report
  • June 2015
  • by Venture Planning Group

“2015-2019 Decentralized/POC Diagnostic Testing Market: Supplier Shares, Country Forecasts for 300 Tests, Emerging Technologies, Competitive Strategies” is VPGMarketResearch’s new report, which provides ...

Global H1n1 Vaccines Industry

March 2015 $ 4 950

Download Unlimited Documents from Trusted Public Sources

Anesthetics Industry in the US

  • June 2015
    32 pages
  • Anesthetics  

    Vaccine  

  • United States  

    North America  

    World  

View report >

Anti-Infective Industry in the US

  • June 2015
    10 pages
  • Anti-Infective  

  • United States  

    Georgia  

View report >

Anti-Infective Industry in the US

  • June 2015
    140 pages
  • Anti-Infective  

    Genitourinary S...  

    Dermatological ...  

  • United States  

View report >

Related Market Segments :

Diagnostic Test

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.